chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lightheaded after injection for a few hours.; Pain at injection sites for about two days; This is a spontaneous report from a non-contactable consumer. A 30-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: unknown), via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to prawns. No concomitant medications were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19 which included Color COVID-19 test via nasal swab on an unknown date in Mar 2021 where the result found to be negative. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021, after the vaccination, the patient had experienced lightheaded after injection for a few hours and had pain at injection sites for about two days. No therapeutic measures, were taken for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event lightheaded after injection for a few hours was resolved on unknown date in Mar2021, while the outcome of pain at injection sites resolved on 27Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Approximately 11:00AM c/o slight stiffness to (L) side of neck radiating to top shoulder. Complaint pain (L)eft ear and pain left temperol region, felt ears plugged-described similar to migraine headache. 10/1/12 c/o stiffness- Oct 1, 2012 c/o (L) eye been very dry also face swollen, Left eye tearing. Consultation 10/1/12 Dr. B/P 170/90 as per client 10/4/12 pain (L) side neck radiation to shoulder. Rx Cefuroxime 500 mg BID.
Nothing until approx 11 hours later.  Awoke with severe lower abdominal pain.  Very weak.  Son helped me get up and clear liquid (water?) came out of eyes, nose, and mouth.  Passed out.  Son helped me to car and I passed out again getting in the car.  Son drove me to the emergency room at hospital.  In severe pain and very weak.  Test done- Fever, Blood, Urine, CT-Scan.  After about 4 hours I was given something for pain through IV and  felt much better in about 10 minutes but still weak. Outcome- Doctor said it was reaction to vaccine and that I have a gallstone  but it was not causing any problems.  Referred to a doctor for the gallbladder.  Told to take 600mg of ibuprofen three times a day for three days.  Was fi
Nausea; malaise; injection site pain; injection site swelling; This is a spontaneous report from a contactable physician (patient herself). A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730; expiry date: unknown) via an unspecified route of administration (arm right), on 04Jan2021 at 15:00, at a single dose, for COVID-19 immunization. Relevant medical history included migraines, seasonal allergies, and history of breast cancer in remission. The patient has no known allergies. Concomitant medication included (FLONASE) fluticasone propionate. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. On 04Jan2021, at 16:45, the patient experienced nausea, malaise, injection site pain, and injection site swelling. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
FEVER, HORRIBLE HEADACHE, NAUSEA, AND EXTREME LETHARGIC. NO TREATMENT
Information has been received from the patient's mother concerning an 8 week old white female (weight 18lbs, 15 oz., height 23 1/2 ") who on 24-APR-2007 was vaccinated with the first dose of Rotateq (lot # 656383/0235U). Concomitant vaccines administered the same day included PEDIARIX, intramuscularly in the left thigh (LOT# AC21B132BA), PEDVAXHIB, intramuscularly in the right thigh (LOT# 654679/1126F) and PREVNAR, intramuscularly in the right thigh (LOT# B08646C). The patient had no illness a time of vaccination. On 26-APR-2007, two days after receiving Rotateq, the patient experienced vomiting and diarrhea. On 03-MAY-2007, the patient was seen in the doctor's office with vomiting and diarrhea. A stool culture was performed which showed no enteric pathogens; negative for ROTAVIRUS, GIARDIA AG, and CRYPTOSPORIDIUM. The patient's outcome was not reported. Additional information has been requested.
Sweating; 38 degrees fever; Feverish chill; Shaking; This is a spontaneous report from a contactable pharmacist (patient). A 29-year-old male patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular on the left arm on 11Jan2021 16:45 at a single dose for COVID-19 immunization. The patient has no medical history and concomitant medications. Previously, the patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), intramuscular on the right arm on 23Dec2020 14:45 for COVID-19 immunization. It was reported that approximately starting 10 hours after the patient received the vaccine (reported as 12Jan2021 03:00) he woke up in the middle of the night feeling feverish chill, but had no fever at the moment. Took Tylenol 1000 mg and slept, but still shaking. Starting around 11:00, he had 38 degrees fever, chill, and sweating for next 18 hours, where Tylenol 1000 mg q (every) 6h briefly dropped temperature to 37 degrees but spiked again when drug is excreted out. Then he maintained with 37 degrees for 12 more hours, then came back to normal. The patient reported that it looks like he had hyperimmune reactions. The events recovered on an unspecified date in Jan2021.
Patient came in today to report he had an outbreak of Shingles. He received vaccination on 05/06/2019 and the symptoms began shortly after. He went to see a doctor who confirmed he did have Shingles and prescribed the patient an antiviral.
flashing of vision; rapid heart rate; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 37-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 09:00 (Lot number: EP7534) at the age of 36 years as dose 1, single for covid-19 immunization.  Relevant medical history included: "Q Fever" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: PHOTOPSIA (non-serious) with onset 08Apr2021 01:00, outcome "recovered" (2021), described as "flashing of vision"; HEART RATE INCREASED (non-serious) with onset 08Apr2021 01:00, outcome "recovered" (2021), described as "rapid heart rate". Therapeutic measures were taken as a result of photopsia, heart rate increased.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was recommended to refer with cardiologist. The patient was not diagnosed with covid-19 prior to vaccination. He was not tested for covid-19 since the vaccination. The patient did not have allergies to medications, food, or other products.  No follow-up attempts are possible. No further information is expected.
Patient called the pharmacy today and informed me that the muscles in her arm are very painful and have been getting worse ever since she got the shot on 12-11-18. She is concerned that it is from the flu shot. Not red or swollen, just muscles are painful. She said the shot was given low in the deltoid, not sure if that is why it hurts so much. I recommended she call her doctor tomorrow and find out what is wrong and let us know. Also we would follow up.
very sick for two days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick for two days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ILLNESS (very sick for two days). On 05-Mar-2021, ILLNESS (very sick for two days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   This case was linked to MOD-2021-062329, MOD-2021-062307 (E2B Linked Report).; Sender's Comments:  MOD-2021-062329: MOD-2021-062307:
Woke up with a fever of 101.2 at 2:30am on 2/3/21. Extreme headache, nausea and body aches.
1-2 hrs after Flu vaccine was given IM, pt appeared pale and became irritable. He was given Tylenol 120mg po. He continued to be fussy and grunting but no sign of respiratory distress. O2 sat 100%. PE - alert, sometimes distractible but no willingness to smile. Follow-up: Please note that pt. was diagnosed with congenital diaphragmatic hernia 2 days later. The irritability resolved. Likely the fussiness was not secondary to an adverse reaction.
This morning she started with headache; She had body aches all day long; she had chills all day long next day after receiving 2nd dose; She thinks she had a low grade fever next day after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose), PYREXIA (She thinks she had a low grade fever next day after receiving vaccine) and HEADACHE (This morning she started with headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose) and PYREXIA (She thinks she had a low grade fever next day after receiving vaccine). On 09-Apr-2021, the patient experienced HEADACHE (This morning she started with headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose), PYREXIA (She thinks she had a low grade fever next day after receiving vaccine) and HEADACHE (This morning she started with headache) outcome was unknown. Reporter did not allow further contact
COVID PNEUMONIA; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown ) dose, 1 total administered, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Dose number in series one. No concomitant medications were reported.  On an unspecified date, the patient had covid pneumonia and Suspected clinical vaccination failure. On SEP-2021, the patient died from covid pneumonia. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the covid pneumonia was fatal and outcome of the suspected clinical vaccination failure was not reported. This report was serious (Death). This report was associated with product quality complaint: 90000204396.; Sender's Comments: V0: 20211161441-Covid-19 vaccine ad26.cov2.s-Covid pneumonia. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 2021161441-Covid-19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event is considered not related. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: COVID PNEUMONIA
Fatigue and crankiness, as well as little pink spots on chest, 6 days after vaccination.  Loss of appetitite on morning of 7th day.  After his nap on 7th day, woke up at 4:00pm with a fever of 103.3 (taken under arm).  He vomited profusely and I called the doctor.  I went in to the pediatric center at 6:25pm.  I told the nurse his symptoms and that he had had his vaccinations a week before.  The doctor came in, and despite the fact that I mentioned the vaccinations, determined that my son had probably gotten a virus.  Two days later, on Sunday, my son developed little pink spots on his face and torso.  It is now Tuesday and he is still tired and weak.  He wants to be carried around all the time as if he is too tired to get around by himself.  This is a dramatic change.  Before the shots, he was fiercely independent and energetic.  I can't say if this will result in a permanent disability, because I've since read that some of the effects from an MMR shot can take months to develop.
diarrhoea; Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
After getting the 3rd dose, within a couple of hours, I had flu like symptoms, no appetite, tired and achy.  This lasted for a few days.  Then I started getting itching on  my scalp and under my breast.  My joints started hurting everywhere followed by extreme fatigue and no appeitite.  The itching worsen especially on my scalp.  I did go see my doctor. The doctor says it looks like yeast and I was prescribed medication  for my scalp and a cream to apply under my breast.   I now notice that I can not tolerate food with yeast, for example, wine, beer, baked goods, and  breads.
Patient reported that he became disoriented and started hallucinating.  His hallucinations lasted until Tuesday.
lack of energy; Chills; Headache; dose received 3; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via intramuscular route of administration in the right arm on 11Nov2021 at 12:30 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as type 1 diabetes, latent autoimmune diabetes in adults (LADA). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included insulin aspart (NOVOLOG), metformin (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN), colecalciferol (VIT D3), iron (MANUFACTURER UNKNOWN), vitamin b complex (B COMPLEX) and unspecified multivitamins (MV); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an intramuscular route of administration in the left arm on 01Apr2021 at 15:15 (at the age of 49-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an intramuscular route of administration in the right arm on 22Apr2021 at 15:00 (at the age of 49-year-old); both as single dose for COVID-19 immunisation. On 12Nov2021 at 02:15, the patient experienced lack of energy, chills and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lack of energy, chills and headache was resolving at the time of this report.
3-4 inch in diameter redness and swelling at site; painful to any touch for 10 days, soreness still present after 3 weeks, pain in neck into shoulder, tiredness
2/17/04 - received ANTHRAX vaccine #1 - no problems 2/27/04 - deployed to foreign country 4/21/04 - received ANTHRAX vaccine #2 and HEP B vaccine #2 4/22/04 - suddenly developed fever of 103, sore throat, body aches, and pulsating/throbbing headaches (5/10) along with photophobia x3 days above sxs worsened 4/27/04 thru 5/4/04 - hospitalized for above sxs - fever of 107 - also developed sob and wheezes - given dx of sinusitis - no response to ZITHRO or ROCEPHIN - LP, head CT, and UA neg - elevated LFTs and RBS - was flown back for further care. 5/18/04 - above viral - like sxs completely dissipated except ha - severity of ha now mild (1/10) but "I have it all day long, everyday" - pain is mostly around the forehead area, bilat temples and "behind my eyes" - "pressure-like" - seen by MD (neurologist at Hospital) - was placed on ZOMIG- BRAIN MRI (7/26) and CXR (7/12) negative. States since receiving above vaccines back in April of last year, noticed having more frequent "sinus infections" - has h/o sinusitis prior to receiving above vaccines but "they were not as frequent and not as bad" - has been on multiple antibiotics for his sxs - ALBUTEROL inh and CLARITIN prn - FLONASE not helpful - sxs "last about a month, then go away for about a week, then gradually come back" - c/o itchiness back of throat, sob, wheezes, PND, chest discomfort, and difficulty taking deep breath when having sinus problems - states has not yet been evaluated by ENT. Last week of December 2004, pt. began to notice joint pain (3/10) "all over my body" - alternating pain mostly felt in knees, wrist, neck, and chest area - "chest area worse, 7/10" - "feels like a growing pain" - "persistent, gradual, throbbing, sharp" pain - joint pain not r/t weather, activities, or time of the day - denies any stiffness - sxs have now worsened - pain now interferes with sleep - able to obtain as little as 1 to 2 hours of sleep at night - c/o fatigue d/t insomnia - "I just have no energy because I feel so tired" - states has not taken any meds to alleviate pain - states has not yet been evaluated by rheumatologist - strong FH (mother) of rheumatoid arthritis. 1/21/04 - pt. seen by his Case Manager - verbalizes his frustrations over his new sxs - states is scheduled to PCS in the next few days - requesting updated clinical summary on his newly developed sxs and an extended exemption for his future ANTHRAX vaccinations - information on ANTHRAX vaccination provided to pt. per pt. request. 1/25/04 - pt. seen by his Case Manager - requesting a copy of his clinical summary written by NP (6/28/04) - above documentation not completed and not signed by NP - a copy of the documentation given to pt. per pt. request - quality of life statement completed by pt. - lab tests (ANA, RF pending at this time) reviewed with pt. - questions answered.  6/23/09 Medical records received DOS 2/17/04 to 7/08/04. Records support previous information received. Assessment: Persistant diffused arthralgia syndrome, frontal sinusitis, chronic recurrent headaches, insomnia, fatigue. No additional coding required. ICD-9 Codes: 719.40, 473.1, 784.0, 780.52, 780.7
2 Days after the injection I suffered extreme neurological symptoms including eye twitching, brain vibrations, heart issues, body vibrations, extreme gastrointestinal issues and severe pain all throughout my body.
Approximately 1/2 hour post vax, the pt developed a 5-6cm erythema at the site of injection which was warm and pruritic. Was seen by an MD and advised to apply a cool compress and take Benadryl. The site was itchy all day and the rash persisted.
This spontaneous report as received from a healthcare worker refers to patients of unknown age and gender. On an unknown date, approximately in 2015 (reported as "on unspecified dates since 08-JUN-2015"), an unspecified number of unspecified patients were vaccinated with GARDASIL (lot # K005881, expiration date 14-JAN-2017). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
4th year getting FLUMIST and patient states this has happened every year, sore start to develop in both nostrils and then scab over. They bleed when nose is blown. Pain scale 0-10 (10 being highest) , patient rates at a 6-7. They last for 2/1/2 months and are painful the entire time.
pt recv vax & was inadvertently re-vaccinated on 31OCT96;1NOV96 pt devel swelling @ the site of vax, disorientation & confusion w/h/a feeling;4NOV96 devel kidney pain as well as pain in lt arm & leg;pt exp diff walking d/t pain;
This spontaneous report was received from a medical assistant/clinical coordinator and refers to a 39 year old patient of an unknown gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a dose of PROQUAD 0.5 ml, once, subcutaneously, lot # N022972, expiration date 19-FEB-2019.5 for prophylaxis. No adverse effects were reported.